NCT06230523: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
- State
- Completed
- Phase
- Phase 2
- People
- 263 taking part
- Started
- 5 Feb 2024
- Primary completion
- 30 May 2025
- Arms
- 1 mg Eloralintide, 3 mg Eloralintide, 6 mg Eloralintide, 9 mg Eloralintide, 6/9 mg Eloralintide, 3/6/9 mg Eloralintide
- Results
- Posted on the registry
- Papers
- doi:10.1016/s0140-6736(25)02155-5
- 30 Jan 2024: Trial registered
- 5 Feb 2024: Trial started
- 14 Aug 2025: Trial completed
- 24 Jun 2026: Trial results posted